Galectin-3: The protein paving new treatment avenues
November 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma
Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …
Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal
November 1, 2018Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma
Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …
Medical Marijuana to be legalised in Thailand and Malaysia as drug becomes available on prescription in UK
November 1, 2018Business Services, Medical Communications Medical marijuana, UK, cannabis, malaysia, thailand
Thailand’s public health ministry is working to make medical marijuana legal by next month. The shift is expected to come …
Novartis cuts 20% of research projects
November 1, 2018Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research
Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …
MSD’s Keytruda/chemo combo scores first-line FDA approval in NSC lung cancer
November 1, 2018Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
MSD’s blockbuster anti-PD-1 immunotherapy has secured another FDA approval, it has emerged, in combination with carboplatin and either paclitaxel or …
Parents should ignore anti-vaccine “social media fake news”, according to England’s medical chief
November 1, 2018Medical Communications England, MMR, Vaccine, anti-vaccine, fake news
England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …
Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths
October 31, 2018Research and Development ITH Pharma, Metropolitan Police, NHS, pharma
An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …
AstraZeneca flogs two drug licenses in $922 million deal
October 31, 2018Research and Development, Sales and Marketing AstraZeneca, pharma
AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional …
Common diabetes drug can protect against age-related macular degeneration, research shows
October 31, 2018Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma
A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …
J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk
October 31, 2018Research and Development, Sales and Marketing FDA, J&J, JJ, invokana, pharma
The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of …
NICE turns down Sanofi’s Caprelsa for rare thyroid cancer
October 31, 2018Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma
NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …
Half of kidney cancer patients initially misdiagnosed
October 30, 2018Manufacturing and Production Cancer, Kidney cancer, NHS, UK, diagnosis
Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. Despite being the …
UK MPs call for greater action on clinical transparency and trial reporting
October 30, 2018Manufacturing and Production, Research and Development UK, c linical transparency, clinical trials, pharma, transparency
The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …
GSK announces results of three year trial into long-lasting HIV injection
October 30, 2018Manufacturing and Production GSK, HIV, drugs, injection, medication
GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …
NHS to receive additional £20.5 billion each year from 2018 Budget
October 30, 2018Manufacturing and Production Budget, Conservatives, Labour, NHS, mental health, politics
The NHS will receive an additional £20.5 billion a year until 2023-24, according to the Budget released yesterday. The confirmation …
Effective preventative therapies for type 2 diabetes are underused, new research argues
October 30, 2018Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes
New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …
Not so crystal clear: The EU’s clinical reporting problem
October 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency
With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …
US court overturns J&J’s Zytiga patent in combination with prednisone
October 29, 2018Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone
A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …
Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration
October 29, 2018Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma
Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …
Vaccine coverage falls by 6.2% since last year
October 29, 2018Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines
Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
